No results for ‘’
Astrazeneca Pharma India Ltd
NSE: ASTRAZEN BSE: 506820
₹7415.50
(1.22%)
Tue, 25 Aug 2026, 04:09 pm
Market Cap (in Cr)18526.25
PE Ratio109.30
Dividend0.49
Health Technology
Pharmaceuticals: Major
24.5KAstrazeneca Pharma India Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 125166 | 7884.41 | 07 Oct 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 125166 | 7887.16 | 07 Oct 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 127119 | 7804.96 | 30 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 127119 | 7802 | 30 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 131308 | 7499.17 | 24 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 131308 | 7506.36 | 24 Sept 2024 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 74097 | 3152.55 | 19 Sept 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 74097 | 3152.55 | 19 Sept 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 6542 | 3152.55 | 19 Sept 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 6542 | 3152.55 | 19 Sept 2022 |
Showing 1–10 of 14
Rows per page: